A functional SNP of interferon-γ gene is important for interferon-α-induced and spontaneous recovery from hepatitis C virus infection

被引:94
|
作者
Huang, Ying
Yang, Huiying
Borg, Brian B.
Su, Xiaowen
Rhodes, Shannon L.
Yang, Kai
Tong, Xiaomei
Tang, George
Howell, Charles D.
Rosen, Hugo R.
Thio, Chloe L.
Thomas, David L.
Alter, Harvey J.
Sapp, Ronda K.
Liang, T. Jake [1 ]
机构
[1] NIH, Ctr Clin, Dept Transfus Med, Bethesda, MD 20892 USA
[2] NIDDKD, Liver Dis Branch, NIH, Bethesda, MD 20892 USA
[3] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA
[4] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[5] Univ Colorado, Hlth Sci Ctr, Div Gastroenterol Hepatol, Denver, CO 80262 USA
[6] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA
关键词
genetics; human study; cytokine; viral clearance; antiviral treatment;
D O I
10.1073/pnas.0609954104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cytokine polymorphisms are associated with disease outcome and interferon (IFN) treatment response in hepatitis C virus (HCV) infection. We genotyped eight SNPs spanning the entire IFN-gamma gene in two cohorts and assessed the association between those polymorphisms and treatment response or spontaneous viral clearance. The first cohort was composed of 284 chronically HCV-infected patients who had received IFN-alpha-based therapy and the second was 251 i.v. drug users who had either spontaneously cleared HCV or become chronically infected. A SNP variant located in the proximal IFN-gamma promoter region next to the binding motif of heat shock transcription factor (HSF), -764G, was significantly associated with sustained virological response [P = 0.04, odds ratio (OR) = 3.51 (confidence interval 1.0-12.5)]. The association was independently significant in multiple logistic regression (P = 0.04) along with race, viral titer, and genotype. This variant was also significantly associated with spontaneous recovery [P = 0.04, OR = 3.51 (1.0-12.5)] in the second cohort. Functional analyses show that the G allele confers a two- to three-fold higher promoter activity and stronger binding affinity to HSF1 than the C allele. Our study suggests that the IFN-gamma promoter SNP -764G/C is functionally important in determining viral clearance and treatment response in HCV-infected patients and may be used as a genetic marker to predict sustained virological response in HCV-infected patients.
引用
收藏
页码:985 / 990
页数:6
相关论文
共 50 条
  • [1] A functional SNP of interferon-γ gene is important for interferon-α-induced and spontaneous recovery from hepatitis C virus infection (vol 104, pg 985, 2007)
    Huang, Ying
    Yang, Huiying
    Borg, Brian B.
    Su, Xiaowen
    Rhodes, Shannon L.
    Yang, Kai
    Tong, Xiaomei
    Tang, George
    Howell, Charles D.
    Rosen, Hugo R.
    Thio, Chloe L.
    Thomas, David L.
    Alter, Harvey J.
    Sapp, Ronda K.
    Liang, T. Jake
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (11) : 4770 - 4770
  • [2] The nature of interferon-α resistance in hepatitis C virus infection
    Pawlotsky, JM
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2003, 16 (06) : 587 - 592
  • [3] Hepatitis C virus infection:: Immune responsiveness and interferon-α treatment
    Jirillo, E
    Pellegrino, NM
    Piazzolla, G
    Caccavo, D
    Antonaci, S
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (02) : 169 - 180
  • [4] Side effects of interferon-α in treating hepatitis C virus infection
    Fontaine, H
    Pol, S
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (03) : 2327 - 2329
  • [5] Functional Comparison of Interferon-α Subtypes Reveals Potent Hepatitis B Virus Suppression by a Concerted Action of Interferon-α and Interferon-γ Signaling
    Chen, Jieliang
    Li, Yaming
    Lai, Fritz
    Wang, Yang
    Sutter, Kathrin
    Dittmer, Ulf
    Ye, Jianyu
    Zai, Wenjing
    Liu, Min
    Shen, Fang
    Wu, Min
    Hu, Kongying
    Li, Baocun
    Lu, Mengji
    Zhang, Xiaonan
    Zhang, Jiming
    Li, Jianhua
    Chen, Qingfeng
    Yuan, Zhenghong
    [J]. HEPATOLOGY, 2021, 73 (02) : 486 - 502
  • [6] Interferon-α in Hepatitis C
    Raymond S. Koff
    [J]. PharmacoEconomics, 1997, 11 : 491 - 491
  • [7] STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α
    Shota Yamauchi
    Kenji Takeuchi
    Kazuyasu Chihara
    Chisato Honjoh
    Yuji Kato
    Hatsumi Yoshiki
    Hak Hotta
    Kiyonao Sada
    [J]. Scientific Reports, 6
  • [8] Interferon-α Induced Lupus in a Patient With Chronic Hepatitis C Virus
    Rizvi, Rubina
    Hojjati, Mehrnaz
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2011, 17 (03) : 152 - 153
  • [9] STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α
    Yamauchi, Shota
    Takeuchi, Kenji
    Chihara, Kazuyasu
    Honjoh, Chisato
    Kato, Yuji
    Yoshiki, Hatsumi
    Hotta, Hak
    Sada, Kiyonao
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [10] Antiviral potency analysis and functional comparison of consensus interferon, interferon-α2a and pegylated interferon-α2b against hepatitis C virus infection
    Erickson, Andrea K.
    Seiwert, Scott
    Gale, Michael, Jr.
    [J]. ANTIVIRAL THERAPY, 2008, 13 (07) : 851 - 862